CTCBIO Ownership

Who are the major shareholders and have insiders been buying or selling?


Recent Insider Transactions

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

What is the ownership structure of A060590?
Owner TypeNumber of SharesOwnership Percentage
Institutions121,0800.506%
Individual Insiders2,896,59812.1%
Private Companies3,168,53013.3%
Public Companies4,177,01517.5%
General Public13,545,55256.7%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.


Top Shareholders

Top 10 shareholders own 43.34% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
17.5%
PharmaResearch Co., Ltd.
4,177,015₩29.3b0%no data
12.1%
Mingoo Lee
2,894,898₩20.3b0%no data
8.8%
Innocence Co. Ltd
2,103,798₩14.8b0%no data
3.4%
The Bridge, Inc.
812,032₩5.7b0%no data
1.06%
Pluto Co., Ltd.
252,700₩1.8b0%no data
0.5%
Dimensional Fund Advisors LP
119,690₩840.2m1.7%no data
0.0071%
Youngmin Kim
1,700₩11.9m0%no data
0.0039%
Samsung Asset Management Company, Ltd.
921₩6.5m0%no data
0.0012%
Mirae Asset Global Investments Co., Ltd.
285₩2.0m-99.1%no data
0.00077%
NH-Amundi Asset Management
184₩1.3m0%no data